Net1 and Myeov: Computationally identified mediators of gastric cancer

British Journal of Cancer

Volumn 94, Issue 8, 2006, Pages 1204-1212

  Leyden, J ^a   Murray, D ^a   Moss, A ^a   Arumuguma, M ^a   Doyle, E ^a   McEntee, G ^a   O'Keane, C ^a   Doran, P ^a   MacMathuna, P ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

DDD; Gastric cancer; Myeov; Net1

Indexed keywords

ANKYRIN; ARGINASE; BENE PROTEIN; CLAUDIN 18; CLAUDIN 2; COMPLEMENT COMPONENT C8; EPS8 LIKE 3 PROTEIN; F BOX PROTEIN; FOCAL ADHESION KINASE 1; GENE PRODUCT; MESSENGER RNA; MYELOMA OVEREXPRESSED PROTEIN; NEUROEPITHELIAL CELL TRANSFORMING PROTEIN 1; NITRIC OXIDE SYNTHASE; PROTEIN CDC42; RAC PROTEIN; RHO GUANINE EXCHANGE FACTOR 6; S 100 CALCIUM BINDING PROTEIN A14; SMALL INTERFERING RNA; THROMBOSPONDIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER MORTALITY; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MYEOV GENE; NET1 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; TIGHT JUNCTION; TRANSCRIPTION REGULATION; UREA CYCLE;

ADENOCARCINOMA; AGED; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTER SIMULATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 33646158477     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603054     Document Type: Article

References (57)

1. Advani AS, Pendergast AM (2002) Bcr-Abl variants: biological and clinical aspects. Leuk Res 26: 713-720
2. Alberts AS, Treisman R (1998) Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J 17: 4075-4085
3. Barranco SC, Townsend Jr CM, Casartelli C, Macik BG, Burger NL, Boerwinkle WR, Gourley WK (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43: 1703-1709
4. Benbow U, Brinckerhoff CE (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15: 519-526
5. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599
6. Chan AM, Takai S, Yamada K, Miki T (1996) Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene 12: 1259-1266
7. Chen B, Zhang XY, Zhang YJ, Zhou P, Gu Y, Fan DM (1999) Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells. World J Gastroenterol 5: 18-21
8. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention1. Cancer Res 52: 6735-6740
9. Dennis JL, Vass JK, Wit EC, Keith WN, Oien KA (2002) Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res 62: 5999-6005
10. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni Jr JF, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402
11. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni Jr JF (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95: 1404-1413
12. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635
13. Faivre J, Forman D, Esteve J, Gatta G (1998) Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer 34: 2167-2175
14. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 1: 39-49
15. Gallagher J, Howlin J, McCarthy C, Murphy EP, Bresnihan B, FitzGerald O, Godson C, Brady HR, Martin F (2003) Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett 551: 8-12
16. Hill CS, Wynne J, Treisman R (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159-1170
17. Jaffe AB, Hall A (2002) Rho GTPases in transformation and metastasis. Adv Cancer Res 84: 57-80
18. Janssen JW, Braunger J, Ballas K, Faust M, Siebers U, Steenvoorden AC, Bartram CR (1999) Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms. Int J Cancer 80: 857
19. Janssen JW, Cuny M, Orsetti B, Rodriguez C, Valles H, Bartram CR, Schuuring E, Theillet C (2002a) MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer. Int J Cancer 102: 608-614
20. Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J (2002b) MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. J Hum Genet 47(9): 460-464
21. Janssen JW, Vaandrager JW, Heuser T, Jauch A, Kluin PM, Geelen E, Bergsagel PL, Kuehl WM, Drexler HG, Otsuki T, Bartram CR, Schuuring E (2000) Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood 95: 2691-2698
22. Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, Tanaka S, Ohmoto Y, Chayama K (2005) Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res 25: 709-713
23. Kawasaki Y, Sato R, Akiyama T (2003) Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nature Cell Biol 5: 211-215
24. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22: 7802-7811
25. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64: 31-49
26. Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y, Yao X, Zheng Y, Fan D (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 10: 6239-6247
27. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JG (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417: 867-871
28. Marinissen MJ, Chiariello M, Gutkind JS (2001) Regulation of gene expression by the small GTPase Rho through the ERK6 (p38-γ) MAP kinase pathway. Genes Dev 15: 535-553
29. Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, Gutkind JS (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14: 29-41
30. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46: 165-186
31. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647-657
32. Ming SC (1998) Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1: 31-50
33. Moss A, Madden S, Mulligan AM, O'Keane C, Henger A, Kretzler M, Brady HR, Doran P, MacMathuna P (2004) Validation of data-mining in identifying novel genes in the colonic polyp-cancer sequence. Endoscopy 36: 477
34. Murray D, Morrin M, McDonnell S (2004) Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism. Anticancer Res 24: 489-494
35. Nardone G (2003) Molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 17: 75-81
36. Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A (2003) Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Alimentary Pharmacol Therapeutics 17: 665-676
37. Oda K, Okabayashi T, Kataoka M, Takeda A, Shibuya Y, Orita K, Tanaka N (1999) Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers. Res Commun Mol Pathol Pharmacol 105: 237-252
38. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL (2003) Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78: 323-335
39. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37: 4-66
40. Pontius JU, Wagner L, Schuler GD (2003) UniGene: a unified view of the transcriptome. The NCBI Handbook, available at http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=handbook.chapter.857
41. Rossman KL, Der CJ, Sondek J (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180
42. Sahai E, Marshall CJ (2002) RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142
43. Sahai E, Olson MF, Marshall CJ (2001) Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 20: 755-766
44. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R (2000) Cancer gene discovery using digital differential display. Cancer Res 60: 4037-4043
45. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159: 83-96
46. Sekiguchi M, Sakakibara K, Fujii G (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61-68
47. Sellin JH, Umar S, Xiao J, Morris AP (2001) Increased betacatenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 61: 2899-2906
48. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC (2000) Gut enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 28: 2969-2976
49. Song DH, Rana B, Wolfe JR, Crimmins G, Choi C, Albanese C, Wang TC, Pestell RG, Wolfe MM (2003) Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol 285: 217-222
50. Sternlicht MD, Bergers G (2000) Matrix metalloproteinases as emerging targets in anti-cancer therapy: status and prospects. Emerging Ther Targets 4: 609-633
51. Symons M, Rusk N (2003) Control of vesicular trafficking by Rho GTPases. Curr Biol 13: 409-418
52. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401
53. Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M (2001) Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology 61: 226-233
54. Vollmers HP, Stulle K, Dammrich J, Pfaff M, Papadopoulos T, Betz C, Saal K, Muller-Hermelink HK (1993) Characterization of four new gastric cancer cell lines. Virchows Arch B Cell Pathol Inc Mol Pathol 63: 335-343
55. Yoshioka K, Nakamori S, Itoh K (1999) Overexpression of small GTPbinding protein RhoA promotes invasion of tumor cells. Cancer Res 59: 2004-2010
56. Yu B, Lane ME, Pestell RG, Albanese C, Wadler S (2000) Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Mol Cell Biol Res Commun 3: 352-359
57. Zhuge Y, Xu J (2001) Rac1 mediates type I collagen-dependent MMP-2 activation: role in cell invasion across collagen barrier. J Biol Chem 276: 16248-16256